Ad
related to: biobest laboratories ltd stock price
Search results
Results From The WOW.Com Content Network
This page was last edited on 28 January 2024, at 22:57 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
A class action suit was filed against Biovail by investors who between December 14, 2006, and July 19, 2007, bought Biovail stock, alleging that the company had failed to disclose that the multi-dose study on depression drug Aplenzin would not be sufficient for the FDA to approve it. [3]
SEHK: 3899 Enric Energy Equipment Holdings Limited SEHK: 3900 Greentown China: SEHK: 3918 NagaCorp Ltd. SEHK: 3928 Zhengzhou Gas Co. Ltd. SEHK: 3933 United Laboratories International Holdings Ltd. SEHK: 3938 Samling Global Ltd. SEHK: 3948 Yitai Coal Co. SEHK: 3958 Orient Securities: SEHK: 3968 China Merchants Bank Co. Ltd. SEHK: 3983 China ...
For premium support please call: 800-290-4726 more ways to reach us
Those profits were also due in part to Mylan's continually raising the price of EpiPens starting in 2009; in 2009 the wholesale price of two EpiPens was about $100, by July 2013 the price was about $265, in May 2015 it was around $461, and in May 2016 the price rose again to around $609, [90] around a 500% jump from the price in 2009.
In 1991 Quintiles GmbH was established in Germany and Quintiles Laboratories Ltd. was established in Atlanta, Georgia. [25] In September 1996, Quintiles purchased Innovex Ltd. of Britain for $747.5 million in stock. [26] Quintiles went public in 1997 and completed a successful secondary stock offering. [27]
Bio Products Laboratory Limited [1] (BPL) is a company involved in the manufacture of human blood plasma products, located in Elstree, Hertfordshire, England. It is run as a commercial business and supplies plasma derived products to the National Health Service in the UK as well as to markets in over 45 countries.
While unveiling the Joint Venture's plans, Sanyo-BPL Pvt Ltd Chairman and Chief Executive Officer, Ajit G Nambiar, said the company expected to post revenues of around ₹ 2,000 crore (equivalent to ₹ 50 billion or US$580 million in 2023) by 2009 and lead the market in consumer electronics and white goods in five years.